BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24846062)

  • 1. Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.
    Rolfo C; Fanale D; Hong DS; Tsimberidou AM; Piha-Paul SA; Pauwels P; Van Meerbeeck JP; Caruso S; Bazan V; Cicero G; Russo A; Giovannetti E
    Curr Pharm Biotechnol; 2014; 15(5):475-85. PubMed ID: 24846062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions.
    Leonetti A; Assaraf YG; Veltsista PD; El Hassouni B; Tiseo M; Giovannetti E
    Drug Resist Updat; 2019 Jan; 42():1-11. PubMed ID: 30544036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview.
    Tibaldi C; D'Incecco A; Lagana A
    Anticancer Agents Med Chem; 2015; 15(6):694-700. PubMed ID: 25612681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer.
    Wei X; Shen X; Ren Y; Hu W
    Curr Pharm Des; 2018 Feb; 23(39):5983-5988. PubMed ID: 29046142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs Change the Landscape of Cancer Resistance.
    Zhu J; Zhu W; Wu W
    Methods Mol Biol; 2018; 1699():83-89. PubMed ID: 29086370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as therapeutic targets in chemoresistance.
    Garofalo M; Croce CM
    Drug Resist Updat; 2013; 16(3-5):47-59. PubMed ID: 23757365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying the role of microRNAs in resistance to epidermal growth factor receptor-targeted agents and novel therapeutic strategies for treatment of non-small-cell lung cancer.
    Maftouh M; Avan A; Galvani E; Peters GJ; Giovannetti E
    Crit Rev Oncog; 2013; 18(4):317-26. PubMed ID: 23614618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and cancer resistance: A new molecular plot.
    Fanini F; Fabbri M
    Clin Pharmacol Ther; 2016 May; 99(5):485-93. PubMed ID: 26875151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.
    Petrek H; Yu AM
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00528. PubMed ID: 31859460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
    Min HY; Lee HY
    Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs associated with therapy of non-small cell lung cancer.
    Lu J; Zhan Y; Feng J; Luo J; Fan S
    Int J Biol Sci; 2018; 14(4):390-397. PubMed ID: 29725260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer.
    Gong FY; Bai T; Zhang DY; Huang CL; Lv J; Wang JL; Hu XD; Wang J; Liu W
    Curr Pharm Des; 2018 Feb; 23(39):5973-5982. PubMed ID: 28714412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
    Zhang K; Yuan Q
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
    Hu S; Yuan Y; Song Z; Yan D; Kong X
    Cell Physiol Biochem; 2018; 51(6):2509-2522. PubMed ID: 30557872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer.
    Sin TK; Wang F; Meng F; Wong SC; Cho WC; Siu PM; Chan LW; Yung BY
    Int J Mol Sci; 2016 Feb; 17(2):237. PubMed ID: 26891293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
    Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L
    Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.